DGKN 2021

Cerenion will take part at the 65th Congress of the German Society for Clinical Neurophysiology and Functional Imaging (DGKN) on the 10th - 12th of March 2021. The three-day event will bring together the scientific community and the industry for a full program on the science and the state of the art of the field.
The scientific program will feature 39 symposia and 130 speakers. The main topics covered will be EEG and MEG, epilepsies, connectivity and functional imaging as well as intraoperative monitoring. The application of neurophysiological methods in the ICU will be discussed scientifically, including a presentation given by Cerenion's CEO and CMedO Dr. Jukka Kortelainen. Cerenion and Bittium will have a joint booth highlighting the Bittium BrainStatus™ with Cerenion C-Trend®.
The event was originally scheduled to take place in Frankfurt on the Main, but will now take place online due to the COVID-19 situation.
For more information please see https://www.dgkn-kongress.de/ or contact Dr. Jukka Kortelainen.

Find out more

Jukka Kortelainen
MD, PhD (Eng.)
CEO, Co-founder
Visit us
Contact us
Cerenion Oy has received support from the European Regional Development Fund of the European Union.
Cerenion Oy
Elektroniikkatie 3
90590 Oulu
Cerenion Oy
Firdonkatu 2 T 63
00520 Helsinki
Call us: +358 50 447 4909
E-mail us:
This website and all of the content therein is for reference purposes only and is not intended to substitute for advice from a licensed healthcare professional. Not available in the United States. Cerenion™, Cerenion C-Trend™, C-Trend™, "The next-generation brain monitoring company"™ and "The pulse of the brain"™ are registered trademarks and/or trademarks of Cerenion Oy. Cerenion C-Trend™ is intended for use by qualified medical practitioners who will exercise professional judgment in its use. Cerenion technology is protected by Intellectual Property Rights. Patents pending worldwide. All rights reserved. © Cerenion Oy 2020.
Powered by:MetaVisual CMSMobile versionDesktop versionLog in© 2017 - 2021 Cerenion Oy